Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reserve ICDs (implantable defibrillators) for sickest patients, says study

This article was originally published in Clinica

Executive Summary

The latest in a series of major trials examining the use of implantable defibrillators (ICDs) for treating life-threatening irregular heartbeats has suggested the devices should be used on only the oldest and sickest patients. Although the researchers were surprised at the high number of patients not suitable for ICDs, the study does add support to previous studies showing that patients at low risk may not be appropriate candidates for the expensive devices.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075922

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel